Funding for this research was provided by:
ALK Abello (none)
Text and Data Mining valid from 2019-03-22
First Online: 22 March 2019
Compliance with Ethical Standards
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: EM is a partner in the Southern California Permanente Medical Group. EM has received research support from the Southern California Permanente Medical Group, grants from ALK Abello, Inc. to study adverse drug reactions, and has served on clinical trial safety and monitoring committees for BioMarin, Ultragenyx, and Audentes.